Clinical trials
Phase 3 Small Cell Lung Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Active, not recruiting | 13 |
| Recruiting | 9 |
| Terminated | 5 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 5 |
| AbbVie | 4 |
| Alliance for Clinical Trials in Oncology | 4 |
| Hoffmann-La Roche | 3 |
| Merck Sharp & Dohme LLC | 3 |
| AstraZeneca | 2 |
| Bristol-Myers Squibb | 2 |
| Case Comprehensive Cancer Center | 2 |
| EpicentRx, Inc. | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 48 |
| Lung Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neoplasms | 4 |
| Brain Neoplasms | 3 |
| Breast Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Bile Duct Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Carcinoma, Small Cell | 2 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.